CXCL10 and systemic sclerosis: Similarly, in fibroblasts treated with serum obtained from patients with SSc-ILD [7.3 × 10−6 (4.7 × 10−6 to 1.3 × 10−5)] cxcl10 was higher compared to those without ILD [2.1 × 10−6 (1.6 × 10−6 to 4.0 × 10−6)], P = 0.009, 95% CI: 2.1 × 10−6 to 1.1 × 10−5].